First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Following his inauguration as President of Nigeria in May 2023, Bola Tinubu announced in his inaugural address that his ...

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease, an official source told AFP on Friday.

The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.